A US court has been urged to revamp the inequitable conduct doctrine, a commonly used provision in patent litigation that allows the validity of a patent to be challenged if one is able to establish that, at the time of applying for a patent, the applicant had wilfully given misleading statements or had withheld material information with the intention to deceive the Patent and Trademark Office1...
Scrip Regulatory Affairs
US court urged to revamp inequitable conduct doctrine in patent litigation
13 August 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
